Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis, Relapsing-Remitting

Explore clinical trials studying Multiple Sclerosis, Relapsing-Remitting. Study availability and eligibility vary by location and protocol.

455 public trials 46 recruiting studies

Multiple Sclerosis, Relapsing-Remitting trial results

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • Research Site Gilbert, Arizona, United States
  • Research Site Long Beach, California, United States
  • Research Site Ocala, Florida, United States
  • Research Site Oldsmar, Florida, United States
View all 34 locations
Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Novartis Investigative Site Truro, Cornwall, United Kingdom
  • Novartis Investigative Site Swansea, England, United Kingdom
  • Novartis Investigative Site Romford, Essex, United Kingdom
  • Novartis Investigative Site Basingstoke, Hampshire, United Kingdom
View all 14 locations
Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Research Site Homewood, Alabama, United States
  • Research Site Sun City, Arizona, United States
  • Research Site La Jolla, California, United States
  • Research Site Los Angeles, California, United States
View all 44 locations
Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Novartis Investigative Site Ostfildern, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Altenholz-Stift, Germany
  • Novartis Investigative Site Aschaffenburg, Germany
  • Novartis Investigative Site Berlin, Germany
View all 26 locations